▲大众点评定年夜饭、支付定金、免责取消示例 通过一系列线上产品改造和数字化升级，美团将传统年夜饭"电话留位、口头约定"的模糊契约模式，改 造为权责清晰、双向保障的交易闭环模式，让预订服务更具确定性。无论是消费者担心预订后无法接 待，还是商家关注的临时取消带来餐位闲置，通过升级后的预订服务，双方的困扰都有望得到改善。 春节临近，年夜饭预订进入高峰。日前，美团升级年夜饭预订服务保障，引入年夜饭预订定金系统"锁 餐位"，VR实景技术"选包间"，把传统的年夜饭预订从"意向登记"升级为"确定性交易"，帮消费者解 决"预订后不接待""到店无座"等困扰。 新模式下，消费者在美团预订年夜饭时，支付定金即完成餐位锁定。若商家无法履约，该商家需向用户 双倍返还定金。 针对消费者可能因行程变动需要取消预订的情况，产品也提供了缓冲空间。比如，商家可自主设置"免 责取消时间"，在此期限前，如果消费者取消预订，定金将全额自动退还；超时后，则需与商家协商确 认。 以"徐记海鲜·MASTER大师店（侨城一号店）"为例，该店已全面接入美团包间VR展示与春节定金系 统，门店负责人表示，规则上线后消费者下单决策更果断更放心，除夕包间目前已基本订满 ...

Core Viewpoint - Wokefeiwan, a leading Chinese cross-border 3C accessories company in Indonesia, has submitted its IPO application to the Hong Kong Stock Exchange, aiming to raise capital for further expansion and digital upgrades [1][6]. Company Overview - Founded in 2014 and headquartered in Shenzhen, Wokefeiwan focuses on the Southeast Asian market, particularly Indonesia, while also expanding into Vietnam, Thailand, and the Philippines [2]. - The company operates over 40 subsidiaries and offices across these countries, leveraging a localized marketing team to reach over 40,000 local small and medium-sized retailers, establishing a unique channel capability and competitive advantage [2]. Product Structure - Wokefeiwan's main products include 3C accessories, small home appliances, and building materials, holding 76 trademarks, 204 patents, and 167 copyrights [4]. - The company has successfully developed its own brands such as VIVAN, ROBOT, SAMONO, and RONA, and has formed deep partnerships with well-known domestic brands like VIVO and DJI [4]. Financial Performance - In 2023, Wokefeiwan achieved a revenue of 908 million yuan, which is projected to grow to 1.049 billion yuan in 2024, reflecting a year-on-year increase of 15.53% [5]. - The gross profit margin improved from 33.6% in 2023 to 36.9% in the first three quarters of 2025, with adjusted net profit rising from 46.8 million yuan in 2023 to 79.04 million yuan in 2024 [5]. IPO Details - The exclusive sponsor for Wokefeiwan's IPO is Huatai International, and the company has completed multiple rounds of financing, with notable shareholders including Alibaba-related entities [6][7]. Market Challenges - Wokefeiwan faces challenges such as high market concentration, with 94.1% of its revenue coming from Indonesia, which poses risks from local regulatory and economic changes [8]. - The company has a significant short-term debt pressure with net current liabilities of 102 million yuan, and its R&D expenditure ratio has decreased from 2.3% in 2023 to 1.3% in the first three quarters of 2025, potentially impacting long-term innovation [8]. Future Plans - The funds raised from the IPO will primarily be allocated to digital upgrades in logistics IT systems, financial systems, supply chain central systems, and data intelligence applications, as well as expanding marketing channels and enhancing brand influence [8]. Industry Insight - Wokefeiwan's journey underscores the growing trend in the cross-border e-commerce sector, demonstrating that Chinese companies can establish sustainable competitive advantages in complex environments through digital infrastructure and localized operations [9].

Core Viewpoint - Ningbo Huaxiang has received approval from the Shenzhen Stock Exchange for its application to issue shares to specific investors, pending final registration approval from the China Securities Regulatory Commission (CSRC) [1] Group 1: Share Issuance Details - The company plans to raise a total of up to 292,073.18 million RMB through this issuance, with net proceeds allocated to various projects including intelligent manufacturing and digital upgrades [1][3] - The issuance will target no more than 35 specific investors, including qualified institutional investors and other legal entities [3][4] - The pricing for the shares will be set at no less than 80% of the average trading price over the 20 trading days prior to the pricing date [4] Group 2: Project Allocation - The funds will be allocated to the following projects: - Wuhu Automotive Parts Intelligent Manufacturing Project: 115,076.86 million RMB - Chongqing Automotive Interior Parts Production Base: 40,695.28 million RMB - R&D Center Construction: 47,672.42 million RMB - Digital Upgrade Project: 38,291.00 million RMB - Working Capital Supplement: 51,000.00 million RMB - The total investment for these projects amounts to 292,735.56 million RMB [3] Group 3: Regulatory and Compliance - The shares issued will be subject to a lock-up period of six months post-issuance, in accordance with regulatory requirements [4] - The maximum number of shares to be issued will not exceed 30% of the company's total share capital prior to the issuance, equating to a maximum of 244,149,936 shares [4]

Core Viewpoint - Ningbo Huaxiang Electronic Co., Ltd. has received approval from the Shenzhen Stock Exchange for its application to issue shares to specific targets, aiming to raise up to 2.921 billion yuan for various projects and working capital [1] Fundraising and Project Allocation - The total amount to be raised is not more than 2.921 billion yuan, which will be allocated to projects including the Wuhu automotive parts intelligent manufacturing project, Chongqing automotive interior parts production base construction, research and development center construction, digital upgrade transformation project, and supplementing working capital [1] Strategic Focus and Industry Positioning - The company plans to leverage its experience in servicing international automotive enterprises and its collaboration with leading domestic brands to establish automotive parts production bases, addressing the downstream demand for localized, diversified, and modular supply [1] - The company aims to keep pace with industry trends by developing intelligent chassis technology and utilizing its expertise in product development and intelligent manufacturing in the automotive parts sector to strategically invest in humanoid robot lightweighting, assembly, and data collection center development, creating new profit growth points and a second growth curve [1] - The company is committed to advancing comprehensive digital upgrades and leveraging AI to enhance operational efficiency, reduce costs, and strengthen core competitiveness [1]

Core Insights - AstraZeneca plans to invest over 100 billion RMB in China by 2030, focusing on cell therapy and radiolabeled drugs, marking a record for foreign pharmaceutical investments in the country [1][5] - The investment will primarily target Wuxi and Taizhou, with a strategic emphasis on these locations rather than spreading investments across multiple cities [1][5] Group 1: Investment Strategy - AstraZeneca's investment in Wuxi is significant as it has been the company's base in China since 1993, evolving into its largest production and packaging hub in the Asia-Pacific region [3][5] - Wuxi's established biopharmaceutical industry, with over 500 enterprises and a market size exceeding 200 billion RMB, provides a conducive environment for AstraZeneca's operations, reducing costs and improving efficiency [5][6] - The company aims to transform Wuxi into a leading digital pharmaceutical center, enhancing its global manufacturing network [5][6] Group 2: Regional Focus - In addition to Wuxi, AstraZeneca is investing in Taizhou, known for its strengths in vaccines and high-end formulations, with plans to expand its production capabilities in antibody-drug conjugates (ADCs) and monoclonal antibodies [7][9] - The Taizhou facility has already received significant investment and is positioned to support AstraZeneca's future growth in biopharmaceuticals, complementing Wuxi's small molecule drug production [9][10] - Qingdao is identified as a strategic point for AstraZeneca, focusing on inhalation aerosols and rare disease drugs, tapping into a growing market for rare diseases in China [10][11] Group 3: Financial Performance - AstraZeneca's revenue for 2024 is projected to reach approximately 54.07 billion USD, with a net profit of around 7.04 billion USD, indicating strong financial health to support its investment plans [15][20] - The Chinese market is crucial for AstraZeneca, contributing about 5.28 billion USD (approximately 37.5 billion RMB) in revenue for the first three quarters of 2025, making it the company's second-largest market globally [18][20] - The oncology segment has become a key revenue driver, accounting for 43% of total revenue in the first three quarters of 2025, reflecting a 16% year-on-year growth [16][17]

（来源：黑龙江日报） 转自：黑龙江日报 中华巴洛克历史文化街区熙熙攘攘的消费人群 。本报记者 李鹏举摄 □本报记者 孙铭阳 孙思琪 供给侧改革 激活消费市场新活力 满足内需的核心在于优质供给。代表委员们普遍认为，只有精准对接消费需求变化，推动供给侧结构性改 革，才能实现消费市场的持续繁荣。 传统商圈作为消费主阵地，其转型升级关乎民生体验与消费活力。省人大代表徐卫国建议，应实施商圈基础 设施提质专项行动，将其纳入城乡建设重点工程，重点解决停车场缺口大、交通拥堵、无障碍设施不完善等 突出问题。通过支持商圈扩建停车场、增设新能源充电桩、升级公共休息区等举措，全面提升消费便利性和 舒适度。同时，要培育新型消费业态，制定省级层面扶持政策，对引进全国首店、区域首店的主体落实财政 奖励，鼓励传统商户转型发展体验式、定制化消费，丰富消费供给场景。 老字号是衔接政策与民生消费的关键纽带，其焕新升级成为扩大内需的重要抓手。省人大代表林珈旭介绍， 企业以供给侧精准发力为核心，按人群、地域分层研发产品，针对露营需求推出小包装系列，为银发人群研 发减盐20%的红肠、低脂益生菌等产品，为川渝地区定制青花椒肠，让百年红肠从"地方特产"变身 ...

中泰证券认为，公路、铁路等交运基础设施是长期配置的核心优选标的，其中头部优质高速公路企业主 业经营具备强稳健性，依托充沛现金流形成高分红的红利资产属性；铁路领域则需重点关注改革深化进 程与转型发展机遇，行业改革将持续驱动板块提质增效。快递行业方面，"反内卷"趋势有效改善价格竞 争格局，申通快递等标的盈利弹性有望充分释放，行业整体竞争态势随政策引导与市场调节持续优化。 交通运输板块具备强抗跌属性，核心支撑清晰可期：依托国民经济刚需底盘，叠加政策持续托底、低估 值高股息构筑安全垫，叠加数字化升级与龙头多元布局强化经营韧性，震荡市中避险与配置价值凸显。 交通运输ETF及其联接基金5/是全市场唯一跟踪中证全指运输指数的ETF基金，其涵盖了A股市场包括 物流、铁路公路、航运港口、机场等，能够充分反映出A股运输行业上市公司的整体表现。 消息面，交通运输部发布数据显示，2025年我国交通运输经济继续保持稳中有进态势。营业性货运量达 到587亿吨，同比增长3.2%。港口货物吞吐量达183.4亿吨，增长4.2%，其中内、外贸分别增长4%和 4.7%。集装箱吞吐量达到3.5亿标箱，同比增长6.8%，内、外贸集装箱分别增长2.4% ...

尼泊尔政府推行关键贸易便利化改革，强制要求所有货物原产地证书的签发必须通过统一的在线单一窗 口系统办理。财政部长拉梅什沃尔·卡纳尔在国际海关日宣布，新证书将内置可验证的二维码以强化防 伪。此项改革旨在彻底实现办理流程线上化，消除企业线下奔波，并通过数字化手段降低文件伪造风 险、提升国际贸易信誉。该措施与海关已推行的基于实际交易的进出口货物透明估价系统相结合，标志 着尼泊尔正通过系统性数字化升级，优化营商环境并增强贸易竞争力。 ...

Core Viewpoint - The company, Huida Sanitary Ware Co., Ltd., anticipates a significant loss for the fiscal year 2025, with projected net profit attributable to shareholders ranging from -216 million to -180 million yuan, indicating a downturn compared to the previous year [2][4]. Group 1: Performance Forecast - The performance forecast period is from January 1, 2025, to December 31, 2025 [3]. - The expected net profit attributable to shareholders is projected to be between -216 million and -180 million yuan, marking a loss compared to the previous year's profit of 138.94 million yuan [4][7]. - The anticipated net profit after excluding non-recurring gains and losses is estimated to be between -285 million and -238 million yuan [5]. Group 2: Previous Year’s Performance - In the previous year, the total profit was 163.39 million yuan, with a net profit attributable to shareholders of 138.94 million yuan and a net profit after excluding non-recurring gains and losses of 67.38 million yuan [7]. Group 3: Reasons for Performance Change - The decline in performance is attributed to factors such as international geopolitical conflicts, industry cycle fluctuations, and changes in market conditions, leading to lower product demand and revenue [9]. - The company is undergoing strategic business adjustments, which include increasing asset impairment losses to align with competitive dynamics and future trends [9]. - The company aims to focus on long-term core values, enhancing its core competitiveness in the sanitary ware sector, and advancing digital upgrades across its supply chain [9].

Core Viewpoint - Huida Sanitary (603385.SH) is expected to report a net loss attributable to shareholders of the parent company between 180 million to 216 million yuan for the year 2025, indicating a significant decline compared to the previous year [1] Financial Performance - The company anticipates a decline in product revenue and gross margin due to factors such as international geopolitical conflicts, industry cycle fluctuations, and changes in market conditions [1] - The expected net loss for 2025 represents a shift from profitability to loss compared to the previous year's statutory disclosure data [1] Strategic Adjustments - In response to the competitive landscape and future development trends, the company is undertaking strategic business adjustments, which include increasing asset impairment loss provisions [1] - The company aims to focus on long-term core directions, emphasizing user value and deepening its main business in sanitary ware [1] Future Focus - Huida Sanitary plans to concentrate resources on two core areas: smart sanitary ware and space solutions, while enhancing its core competitiveness [1] - The company is committed to a comprehensive digital upgrade across the entire supply chain, aiming to establish an integrated smart management operation platform to support business model innovation and data-driven decision-making [1]